Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Short-term Investments history
Currency unavailable · from the balance sheet
No Short-term Investments data reported for this period type.
Short-term Investments vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $989.18M USD | +134.8% | +218.1% | 89.9% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $728.76M USD | +182.6% | — | 59.2% |
ALMSAlumis Inc. Common Stock | Jun 2026 | $438.59M USD | +31.1% | +48.2% | 78.2% |
| Jun 2026 | $362.5M USD | -9.8% | +57.8% | 40.9% | |
| Mar 2026 | $76.76M USD | +2.4% | -25.7% | 38.6% | |
| Mar 2026 | $37.99M USD | -84.3% | -41.7% | 11.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €0 EUR | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +16.7% | +48.2% | 39.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.